Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer
Titel:
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer
Auteur:
Rayson, Daniel Lupichuk, Sasha Potvin, Kylea Dent, Susan Shenkier, Tamara Dhesy-Thind, Sukhbinder Ellard, Susan L. Prady, Catherine Salim, Muhammad Farmer, Patricia Allo, Ghasson Tsao, Ming-Sound Allan, Alison Ludkovski, Olga Bonomi, Maria Tu, Dongsheng Hagerman, Linda Goodwin, Rachel Eisenhauer, Elizabeth Bradbury, Penelope